In vitro and in vivo activities of formycin B against Trypanosoma cruzi.
AUTOR(ES)
McCabe, R E
RESUMO
The inosine analog formycin B was examined for in vitro and in vivo activities against Trypanosoma cruzi. concentration of formycin B as low as 0.1 microgram/ml markedly inhibited intracellular multiplication of T. cruzi strains both in macrophages and in L929 cells. Mice infected with 10(5) blood form trypomastigotes of the highly virulent strain Y of T. cruzi were completely protected against death by treatment with 11.8 or 5.9 mg of formycin B per kg administered intraperitoneally each day for 19 days. Four different strains of T. cruzi were used, and each was susceptible to formycin B administered either intraperitoneally or orally. Parasitological cure, however, was not achieved with any of the treatments used, including prolonged treatment for up to 10 weeks. Formycin B has a remarkable capacity for inhibiting the in vitro intracellular replication of T. cruzi and protecting mice against death due to the acute infection with the organism. It does not appear, however, to be able to completely eliminate T. cruzi from infected mice.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=180081Documentos Relacionados
- Differences in microbicidal activities of human macrophages against Toxoplasma gondii and Trypanosoma cruzi.
- Evaluation in vitro and in vivo of the combined action of the hormones Dehydroepiandrosterone (DHEA) and Melatonin (MEL) against Trypanosoma cruzi.
- In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi
- In vitro 3' end processing and poly(A) tailing of RNA in Trypanosoma cruzi.
- Transportador ABC e resistência a benznidazol em Trypanosoma cruzi.
